Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2026Open Access

Bio-Manguinhos and new generation of vaccines: consolidation of mRNA-LNP production and evaluation of critical quality attributes at pilot scale

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDaniele RochaECElaine CostaSRSthefanie Ribeiro

Discussion

Loading...

Member takes

Overview

Presentation discusses mRNA-LNP vaccine production quality in pilot scale by Bio-Manguinhos, indicating significant advancements.

Key Points

  • The aim is to evaluate the production and critical quality attributes of mRNA-based vaccines at a pilot scale.
  • Pilot-scale production of mRNA-lipid nanoparticle (LNP) vaccines
  • Assessment of critical quality attributes during production
  • Participation in the International Symposium on Immunobiologicals
  • Successful consolidation of mRNA-LNP production processes
  • Improvement in the evaluation of vaccine quality attributes
  • Presentation aligns with current advancements in vaccine technology

Cite This Study

Rocha et al. (2026) studied this question.

synapsesocial.com/papers/6a192c0ffab5b468c4415146https://doi.org/10.35259/isi.2026_76327
View Full Paper
Ask AI
Bookmark
Share